Related Experiment Videos
[Chemotherapy for head and neck cancer]
1Dept. of Otorhinolaryngology, National Defense Medical College, Saitama, Japan.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|March 4, 2000
Summary
Neoadjuvant chemotherapy, particularly cisplatin-based regimens, improves survival and organ preservation in head and neck cancers. It is effective for unresectable tumors and advanced nasopharyngeal cancer, offering survival benefits and laryngeal preservation possibilities.
Area of Science:
- Oncology
- Head and Neck Surgery
- Medical Oncology
Context:
- Head and neck cancers often present as advanced or recurrent disease.
- Chemotherapy was initially explored for palliative care in these cases.
- Cisplatin-containing regimens are recognized as highly effective.
Purpose:
- To evaluate the efficacy of neoadjuvant chemotherapy in head and neck cancers.
- To assess survival benefits and organ preservation potential.
- To determine optimal chemotherapy strategies for different cancer types and stages.
Summary:
- Neoadjuvant chemotherapy, especially cisplatin plus 5-fluorouracil, shows significant efficacy in head and neck cancers.
- Studies demonstrate survival benefits in advanced nasopharyngeal cancer and locally unresectable oral cavity, pharynx, nose, and paranasal sinus cancers.
- Organ function preservation, including laryngeal preservation for T2/T3 laryngeal and hypopharyngeal cancer, is achievable.
Impact:
- Neoadjuvant chemotherapy offers a survival advantage and improved quality of life through organ preservation.
- It establishes chemotherapy as a crucial component in the multimodal treatment of head and neck cancers.
- Tailored chemotherapy approaches, including concurrent chemoradiotherapy, are recommended for advanced stages and specific cancer sites.